Supreme Court

Mayes wins extended delay of Civil War-era abortion law ruling to mull appeal to U.S. Supreme Court

“Arizona Attorney General Kris Mayes has further delayed the Arizona Supreme Court’s decision to revive a near-total abortion ban from 1864 — and she’s still eyeing an appeal to the U.S. Supreme Court.  Since the Arizona Supreme Court’s bombshell ruling that the Civil War-era law could once again be enforced earlier this year, the law was repealed by the state legislature. While reproductive rights proponents celebrated the move at the time, they also worried that the legislature’s action would simply delay the ban’s reinstatement, because laws don’t become effective until 90 days after the legislative session ends. But that fear was laid to…
Read More

Abortion bans still leave a ‘gray area’ for doctors after Idaho Supreme Court case

"The Supreme Court’s abortion ruling on Thursday is a narrow one that applies only to Idaho and sends a case back down to the appeals court. Confusion among doctors in states that have strict abortion bans remains widespread. The case concerns the kinds of situations in which emergency room doctors could end a pregnancy. Under Idaho law, it is a felony to provide nearly all abortions, unless the life of the mother is at risk. But what if a pregnancy threatens her health? For now, those abortions can happen in Idaho emergency rooms...."
Read More

Iowa’s Supreme Court tells lower court to let strict abortion law go into effect

"The Iowa Supreme Court has reversed a lower court ruling that put a temporary block on the state’s strict abortion law, and is telling the lower court to let the law take effect. In Friday’s ruling, the high court told the lower court to dissolve the temporary injunction and continue with further proceedings. The new law bans most abortions after about six weeks of pregnancy and before many women know they are pregnant...."
Read More

Abortion Pill Access Is Still Under Threat After SCOTUS Ruling, Legal Experts Warn

"....Last week’s ruling was widely expected, legal experts say. “Anybody that values reproductive freedom and the scientific integrity of the [U.S. Food and Drug Administration] can breathe a sigh of relief,” says Lawrence Gostin, a professor of global health law at Georgetown University. But “it would be foolish to declare victory” for abortion rights, he says. The ruling was a narrow legal technicality that didn’t go into the case’s actual merits. It’s quite possible, Gostin says, that the Court could make future rulings that restrict access to medication abortion and usurp the FDA’s broader authority to regulate drug safety...."
Read More

Abortion rights: Tracking state lawsuits two years after Roe reversal

"Nearly two years after the U.S. Supreme Court overturned its landmark 1973 ruling in Roe v. Wade, litigation over abortion has exploded. Justice Samuel Alito wrote in 2022's Dobbs v. Jackson Women's Health Organization that the court's longstanding precedent had "enflamed debate and deepened division." He said it was time to take the abortion issue out of the hands of the court and return it "to the people's elected representatives."..."
Read More

Reagan-era emergency health care law is the next abortion flashpoint at the Supreme Court

Two years after ending the national right to abortion by overturning Roe v. Wade, the Supreme Court will scrutinize one of the marquee efforts by the Biden administration to preserve abortion access in the post-Roe v. Wade era.
Read More

Supreme Court Skeptical of Push to Curb Access to Abortion Pill

"In the 2022 case of Dobbs v. Jackson Women’s Health Organization, the U.S. Supreme Court overturned Roe v. Wade and held that there is no constitutional right to an abortion, returning the legality of abortion to the states. The court must now decide if access to mifepristone, the drug used in medication abortions, should be restricted. During oral arguments last week, most of the justices seemed reluctant to roll back access to the drug. Instead, they focused on whether the plaintiffs had a legal right, or standing, to sue and questioned whether the doctors in the case, Food and Drug Administration v. Alliance for…
Read More

No One Could Say: Accessing Emergency Obstetrics Information as a Prospective Prenatal Patient in Post-Roe Oklahoma

In the wake of the 2022 U.S. Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, Oklahoma residents are currently living under three overlapping and inconsistent state abortion bans that, if violated, impose severe civil and criminal penalties on health care providers.
Read More

Supreme Court hears mifepristone arguments as protests gather outside: Highlights

"Abortion providers responded to today's oral arguments by emphasizing the safety and effectiveness of mifepristone, stressing that reduced access to the drug could threaten public health. “The very existence of this case puts every other FDA-approved medication at risk of being taken off the market or restricted for political reasons,” Alexis McGill Johnson, CEO of Planned Parenthood Federation of America, said in a statement...."
Read More

A ‘dangerous precedent’: Doctors and patient advocates fear restricted access to abortion pill

"About two years after the Supreme Court overturned Roe v. Wade, the court on Tuesday will revisit the issue of reproductive rights, this time contemplating whether to limit access to mifepristone, the first of two pills used in medication abortion. Ahead of oral arguments and eventual ruling, doctors and patient advocates are expressing alarm about what might happen if the high court decides to tighten access to the drug...."
Read More

Supreme Court hears abortion arguments

The Montana Supreme Court on Wednesday heard arguments in a case about whether minors must receive parental consent for an abortion. This case is revisiting a fraught legal question that Montana voters, lawmakers and residents have grappled with for more than a decade.
Read More

U.S. publisher retracts studies cited by Texas judge in suspending abortion pill’s approval

"A U.S. scientific publisher has retracted two studies, largely due to their methodology, that a Texas judge cited last year in his ruling suspending federal approval of the abortion pill mifepristone in response to a lawsuit by anti-abortion doctors and medical associations. The retraction Monday by Sage Publications came less than two months before the U.S. Supreme Court is expected to hear an appeal by President Joe Biden's administration in that case. Mifepristone, the first in a two-pill regimen for medication abortion, remains available while the appeal is pending...."
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.